News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
NCODA Hosts Third Annual International Executive Council Summit
NCODA /LinkedIn
Mar 28, 2025, 14:24

NCODA Hosts Third Annual International Executive Council Summit

NCODA shared a post on LinkedIn:

“NCODA proudly hosted our third Annual International Executive Council Summit in Pula, Croatia, bringing together oncology leaders from around the world. We engaged in forward-thinking discussions on advancing medication access, innovation, education, and workforce development in cancer care.

NCODA domestic and international Executive Council members also delivered six impactful presentations at the second School of Rational and Safe Pharmacotherapy Congress, reinforcing our commitment to sustainable, efficient, and patient-centered oncology practices.

Thank you to our international partners in Croatia and around the world for your hospitality and relentless effort in pursuit of improving patient care!”

NCODA

cancer NCODA NCODA Annual International Executive Council Summit OncoDaily Oncology
Special Coverage
Insight
Jun 13, 2025, 05:15
Yuji Uehara: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC
Insight
Jun 13, 2025, 04:29
MD Anderson Research Highlights
Drugs
Jun 13, 2025, 04:16
Pemigatinib (Pemazyre): Uses in Cancer, Side effects, Dosage, Expectation and more
Insight
Jun 13, 2025, 03:49
Diego A. Díaz García shared an article on roles of the gut microbiota in immune-related adverse events - mechanisms and therapeutic intervention
Oncolibrary
Jun 13, 2025, 03:18
Etiology: Understanding the Causes and Origins of Disease
Insight
Jun 12, 2025, 19:31
Amar Kishan: UCLA Launches ILLUSION Trial on 2 mm PTV Margins in CT-Guided SBRT
Insight
Jun 12, 2025, 19:16
Eric K. Singhi: U.S. FDA Approved Taletrectinib for ROS1+ mNSCLC
Insight
Jun 12, 2025, 19:07
Rami Manochakian: FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer Based on TRUST Trials
Blog
Jun 12, 2025, 18:57
Edward Christopher Dee and Layal Al Mahmasani Highlighted Participation in Inaugural Global Oncology Trainee Track at MSK
Blog
Jun 12, 2025, 18:40
Register for the 2nd National Cancer Summit - National Cancer Institute of Kenya
Blog
Jun 12, 2025, 18:30
ESMO Daily Reporter Interviewed Paolo Tarantino on ADCs in Breast Cancer Care
Insight
Jun 12, 2025, 18:22
Bruna Pellini: Chemotherapy Plus Anti-PD-1 or Anti-PD-L1 in Advanced PD-L1-Negative sqNSCLC